about
Prognostic stratification of colorectal cancer patients: current perspectivesStem cells and colorectal carcinogenesisTumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future ProspectsDepth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancerReview of histopathological and molecular prognostic features in colorectal cancerVascular endothelial growth factor (VEGF) receptor expression correlates with histologic grade and stage of colorectal cancerIntegrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression.Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type.Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR expression of pancreatic cancer BxPC-3 cells at the invasive front in vitro, and promotes tumor growth and invasion in vivo.Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagusBiological predictors of survival in stage II colorectal cancer.Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.Prognostic significance of tumor budding in gastrointestinal tumors.Tumour budding: a promising parameter in colorectal cancer.Clinicopathological characteristics of T1 colorectal cancer without background adenoma.Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition.Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era.Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis.Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma.Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.Long-term outcomes of locally or radically resected T1 colorectal cancer.Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor BudsRole of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.Colorectal cancer: prognostic values.Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions.Histopathologic risk factors for lymph node metastasis in patients with T1 colorectal cancer.Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.Sialyl Lewisx expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer.Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer.Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.Tumor budding is an independent prognostic factor for prediction of lymph node metastasis in oral squamous cell carcinoma.
P2860
Q26823543-0BD5B61E-F716-4898-9767-C63FDBA22B8AQ28073597-34DD2F60-927F-46C4-B29F-250225D16646Q28075498-6A1D6B47-DBC8-4876-9FE8-EE55E7D52A3FQ34497238-1A885267-1568-4C88-8B5D-6215EBC162D6Q34657323-9DC5B67C-EBB5-4D0D-BAA9-F1B357E29542Q34764162-0BD7CFDC-09FF-4B8B-AE7E-6633C1C8E069Q35783902-A6D3A389-9E21-4CF5-9059-46CC1E643E01Q36014210-60976201-5C41-471F-9290-085F2E5A2054Q36054317-FE5AA435-3322-45BA-A012-A8161AEF3870Q36742326-738775B5-5648-46BF-9D18-88CDFA9D7C12Q37098252-0B176C77-D92C-45EF-97EF-483143CF7F30Q37560459-F096F596-0166-4C6D-9503-36925EA33C00Q37594364-F0C69EE0-7BF7-4C32-B763-616D75DFCF05Q37840946-2679EC4A-A82B-4076-819E-7CCA2799CE88Q37945638-F0BF29BA-0A36-41D7-88D8-99AB399FCEBDQ38005295-BA2F67C6-A8A6-4698-85D4-94152F47C7ACQ38072135-DDEB59C8-B55E-472D-B182-FDB6EA91FC98Q38142723-DC8DEE2E-3281-4E20-AB82-3351BBB2C6CDQ38174869-BDFAEC5E-C89D-498A-9AA8-FF89DF56F155Q38241953-740CB8CB-F8E6-40E4-9EA8-6A649808EE96Q38494430-8CC64F13-4927-4EDD-A23F-A251F5F23E1EQ38555225-C29AF606-5F0C-43EF-8B76-F8BCB965176DQ38836817-1D9392E1-ECF2-4A15-8296-6D54CBF569CCQ38947246-7D554CA6-0911-4177-94E3-E7E2ACD4C3E8Q38979960-A454A102-2603-4440-B133-4A93FBA61383Q40046627-C1F14C03-D3E7-4AFA-A4E3-B8E635052725Q41109319-97BC031D-B324-4C41-8A56-78BE91D3D7A0Q41649045-CE360383-EE2F-4C90-AA39-AF0C76A84084Q42092317-54587161-EE7E-4C9E-8FC3-022D118E62B6Q42379697-F5F09E3F-235D-4EB1-A5BA-0E06E6608368Q42816552-368406C4-3A2D-487E-B990-18B2796E1F4FQ43587615-89DFC031-44E7-45FC-8C05-493552E6023AQ43982501-00FE4164-C6E8-4B62-8335-41CFA119D277Q45389961-7CDE6DA0-03AB-4D21-9843-825F530D4BADQ45838808-57E71A39-409F-48AA-A39B-065FA8789C64Q49164714-EB695F83-F4E0-40C2-BA09-F1080C511589Q53193786-AB9A2579-8879-4118-A41B-06E994E6C733Q53383475-0006AD64-7660-45C7-B056-60B837747E59Q53621197-5F14D25D-586D-4C0A-A477-65090E69A204Q53652947-870E1225-0382-4D43-99A1-7BFC1B0E6283
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A new prognostic staging system for rectal cancer.
@ast
A new prognostic staging system for rectal cancer.
@en
A new prognostic staging system for rectal cancer.
@nl
type
label
A new prognostic staging system for rectal cancer.
@ast
A new prognostic staging system for rectal cancer.
@en
A new prognostic staging system for rectal cancer.
@nl
prefLabel
A new prognostic staging system for rectal cancer.
@ast
A new prognostic staging system for rectal cancer.
@en
A new prognostic staging system for rectal cancer.
@nl
P2093
P2860
P1433
P1476
A new prognostic staging system for rectal cancer.
@en
P2093
Ashley B Price
Hideki Ueno
Hidetaka Mochizuki
Ian C Talbot
Jeremy R Jass
Kay H Wilkinson
P2860
P304
P356
10.1097/01.SLA.0000143243.81014.F2
P407
P577
2004-11-01T00:00:00Z